Tag Archives: Epclusa

September, 2018

October, 2017

August, 2017

February, 2017

  • 22 February

    The 2017 Hepatitis C Treatment Landscape

    Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, particularly when it comes to direct-acting antiviral medications. This included various drug approvals and access improvements for hepatitis C medications, including Daklinza, Epclusa, Sovaldi/velpatasvir, Viekira, and Zepatier. As we make our way deeper into 2017, …

July, 2016

  • 5 July

    Introducing Epclusa

    The treatment options for hepatitis C infections just gained a member to the club. There are six genotypes (numbered 1-6) of the hepatitis C virus. Previously, hepatitis C medications generally worked best for only one or a few genotypes. Consequently, identifying a patient’s genotype was an important part of the …

June, 2016